site map | search | contact | disclaimer     December 01, 2008   QLT INC. OUR BUSINESS IS SCIENCE. OUR PRODUCT IS LIFE. QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies. Our research and development efforts are focused on pharmaceutical products in the field of ophthalmology. In addition, we utilize three unique technology platforms, photodynamic therapy, Atrigel® and punctal plugs with drugs, to create products such as Visudyne® and Eligard® and future product opportunities. CURRENT CLINICAL TRIALS All Trials Employee Login QLT To Repurchase Up to US$50 Million of Common Shares December 01, 2008 QLT Announces Third Quarter Results for 2008 October 28, 2008 QLT Announces Encouraging Phase II Data From Core Study of Punctal Plug Drug Delivery System October 28, 2008 More press releases in our News Center... Rodman & Renshaw 10th Annual Healthcare Conference QLT is scheduled to present on Wednesday, November 12, 2008 at 11:10 a.m. ET in New York City. Click here to listen to the presentation. Q3 2008 Earnings Conference Call QLT will broadcast its Q3 2008 Earnings Conference Call on Tuesday, October 28 at 8:30 am ET. Click here to listen to the webcast. UBS 2008 Global Life Sciences Conference QLT presented on Thursday, September 25, 2008 at 12:30 p.m. ET in New York City. Click here to listen to a replay of the presentation. Copyright © 2000 - 2008 QLT Inc. All rights reserved. See legal terms for use of site and Privacy Policy.